Sanaria Inc.

This study tested a new malaria vaccine made from genetically weakened parasites that stop growing in the liver and cannot cause blood-stage infection. The goal was to see if it is safe and triggers a strong immune response. The trial involved 75 healthy adults and children in Bu…

This study tested two experimental malaria vaccines in 345 healthy Indonesian soldiers deployed to a malaria-prone region. The goal was to see if the vaccines could safely prevent natural malaria infection. Participants received either a vaccine or a placebo, and researchers trac…